Publications by authors named "Thierry Chinet"

Claim this Profile
B
BEST study: one-year descriptive follow-up of bevacizumab treatment in hereditary haemorrhagic telangiectasia post-BABH interventional study.
Sophie Dupuis-Girod, Evelyne Decullier, Sophie Rivière, Christian Lavigne, Vincent Grobost, Thierry Chinet

Ther Adv Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exclusive oral antibiotic treatment for hospitalized community-acquired pneumonia: a post-hoc analysis of a randomized clinical trial.
Aurélien Dinh, Clara Duran, Jacques Ropers, Frédérique Bouchand, Laurène Deconinck, Thierry Chinet

Clin Microbiol Infect· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial.
Sophie Dupuis-Girod, Sophie Rivière, Christian Lavigne, Anne-Emmanuelle Fargeton, Brigitte Gilbert-Dussardier, Thierry Chinet

J Intern Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myocardial Infarction in a 29-Year-Old Woman Leads to Diagnosis and Treatment of a Rare Disease.
Carma Karam, Nicolas Mansencal, Etienne Puymirat, Etienne Charpentier, Aurélien Palmyre, Thierry Chinet

Chest· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT.
Thi Thao Truc Le, Guillaume Martinent, Sophie Dupuis-Girod, Antoine Parrot, Anne Contis, Thierry Chinet

Orphanet J Rare Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated With Treatment Failure in Moderately Severe Community-Acquired Pneumonia: A Secondary Analysis of a Randomized Clinical Trial.
Aurélien Dinh, Clara Duran, Jacques Ropers, Frédérique Bouchand, Benjamin Davido, Thierry Chinet

JAMA Netw Open· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
phenotype overlaps with hereditary haemorrhagic telangiectasia: two case reports.
Mostafa El Hajjam, Ahmed Mekki, Aurelien Palmyre, Melanie Eyries, Florent Soubrier, Thierry Chinet

J Med Genet· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occurrence of pulmonary embolism related to COVID-19.
Marie Hauguel-Moreau, Mostafa El Hajjam, Quentin De Baynast, Antoine Vieillard-Baron, Anne-Sophie Lot, Thierry Chinet

J Thromb Thrombolysis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial.
Aurélien Dinh, Jacques Ropers, Clara Duran, Benjamin Davido, Laurène Deconinck, Thierry Chinet

Lancet· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Hedgehog Pathway Activation and Increase of Plasma Wnt1 Protein Are Associated with Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer.
Camille Mehlman, Paul Takam Kamga, Adrien Costantini, Catherine Julié, Coraline Dumenil, Thierry Chinet

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis.
Mathilde Roumier, Romain Paule, Alexandre Vallée, Julien Rohmer, Marie Ballester, Thierry Chinet

J Clin Immunol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Biomarkers Screening by Multiplex ELISA Assay in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
Adrien Costantini, Paul Takam Kamga, Catherine Julie, Alexandre Corjon, Coraline Dumenil, Thierry Chinet

Cancers (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prioritising outcomes for evaluating eosinophil-guided corticosteroid therapy among patients with acute COPD exacerbations requiring hospitalisation: a Delphi consensus study.
Carey Meredith Suehs, Maéva Zysman, Cécile Chenivesse, Pierre-Régis Burgel, F Couturaud, Thierry Chinet

BMJ Open· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression.
Etienne Giroux Leprieur, Zofia Hélias-Rodzewicz, Paul Takam Kamga, Adrien Costantini, Catherine Julie, Thierry Chinet

J Immunother Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial.
Cesare Gridelli, Tudor Ciuleanu, Manuel Domine, Aleksandra Szczesna, Isabel Bover, Thierry Chinet

Br J Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher prevalence of splenic artery aneurysms in hereditary hemorrhagic telangiectasia: Vascular implications and risk factors.
Jacques Sellier, Carma Karam, Alain Beauchet, Axel Dallongeville, Stephen Binsse, Thierry Chinet

PLoS One· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients.
Philippine Dacosta-Noble, Adrien Costantini, Coraline Dumenil, Jennifer Dumoulin, Pierre Helly de Tauriers, Thierry Chinet

PLoS One· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study.
Camille Mehlman, Jacques Cadranel, Gaelle Rousseau-Bussac, Roger Lacave, Anaïs Pujals, Thierry Chinet

Lung Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Biomarkers and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: New Tools for Better Patient Selection?
Adrien Costantini, Paul Takam Kamga, Coraline Dumenil, Thierry Chinet, Jean-François Emile

Cancers (Basel)· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary gas exchange in hereditary hemorrhagic telangiectasia patients with liver arteriovenous malformations.
Carole de Picciotto, Mostafa El Hajjam, Carma Karam, Thierry Chinet, Marcel Bonay

Respir Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab.
Julia Ouaknine Krief, Pierre Helly de Tauriers, Coraline Dumenil, Nathalie Neveux, Jennifer Dumoulin, Thierry Chinet

J Immunother Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute exacerbation of COPD during pulmonary rehabilitation: outcomes and risk prediction.
Bertrand Herer, Thierry Chinet

Int J Chron Obstruct Pulmon Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Crizotinib and Osimertinib or Erlotinib Might Overcome MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutated Adenocarcinoma.
Etienne Giroux-Leprieur, Coraline Dumenil, Thierry Chinet

J Thorac Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab.
Adrien Costantini, Catherine Julie, Coraline Dumenil, Zofia Hélias-Rodzewicz, Julie Tisserand, Thierry Chinet

Oncoimmunology· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer.
Etienne Giroux Leprieur, Guillaume Herbretau, Coraline Dumenil, Catherine Julie, Violaine Giraud, Thierry Chinet

Oncoimmunology· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis